Skip to content
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
BioTechGrid BioTechGrid
  • Home
  • Biotechnology
  • Medical Technology
  • Research
  • Genetics
  • Press Releases
    • Business Wire
    • GlobeNewswire
    • PRNewswire
  • Contact
  • Home
  • Biotechnology
  • A year on from Big Pharma’s pull-back from the UK, has anything changed?

A year on from Big Pharma’s pull-back from the UK, has anything changed?

August 27, 2026Posted inBiotechnology

September 2025 marked a low point for relations between the U.K. government and Big Pharma. Fierce reached out to the companies involved to see if they’ve softened their stance.

Post navigation

Previous Post
Chutes & Ladders—Vivace revs up C-suite ahead of pivotal push
Next Post
Multi-Academic Study Finds No Link Between Pesticide Exposure and Autism Traits multi-academic-study-finds-no-link-between-pesticide-exposure-and-autism-traits

Recent Posts

  • Sartorius and NIBRT Partner on Intensified and Continuous Bioprocessing Training Center
  • Mithrl Raises $20M to Expand Deployment of Its Biomedical World Model Across Biopharma
  • Goa Therapeutics launches with ‘immeasurably huge’ vision of creating Narcan for alcohol
  • DPHARM: How to address the clinical trial enrollment crisis?
  • After one failed acquisition attempt, Lisata finds lifeline in Marea merger

Archives

  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • March 2024
  • January 2024
  • September 2023

Privacy Policy    Terms

Scroll to Top